These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20876375)

  • 1. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.
    Gordon NC; Png K; Wareham DW
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5316-22. PubMed ID: 20876375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.
    Wareham DW; Gordon NC; Hornsey M
    J Antimicrob Chemother; 2011 May; 66(5):1047-51. PubMed ID: 21393131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
    Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
    O'Hara JA; Ambe LA; Casella LG; Townsend BM; Pelletier MR; Ernst RK; Shanks RM; Doi Y
    Antimicrob Agents Chemother; 2013 May; 57(5):2103-8. PubMed ID: 23422916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY; Ng LS; Tan E; Huang G
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
    Liu B; Liu Y; Di X; Zhang X; Wang R; Bai Y; Wang J
    Rev Soc Bras Med Trop; 2014 Jul; 47(4):451-6. PubMed ID: 25229285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
    Phee LM; Betts JW; Bharathan B; Wareham DW
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4544-50. PubMed ID: 25987639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of imipenem/colistin methanesulfonate combinations against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii.
    Leu HS; Ye JJ; Lee MH; Su LH; Huang PY; Wu TL; Huang CT
    J Microbiol Immunol Infect; 2014 Oct; 47(5):406-11. PubMed ID: 23834782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin-glycopeptide combinations against multidrug-resistant
    Sanderink D; Cassisa V; Chenouard R; Mahieu R; Kempf M; Dubée V; Eveillard M
    Future Microbiol; 2019 May; 14():581-586. PubMed ID: 31172805
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp.
    Rady OMSM; El-Attar L; Amine A
    J Antibiot (Tokyo); 2022 Mar; 75(3):181-184. PubMed ID: 35091666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.
    Bedenić B; Beader N; Godič-Torkar K; Prahin E; Mihaljević L; Ćačić M; Vraneš J
    J Chemother; 2016 Oct; 28(5):375-82. PubMed ID: 26319682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.